Skip to content

TriSalus Life Sciences, Inc. TLSI Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$56.55M+172%$20.79M-9.8%$23.04M-14.2%$26.84M+101%$13.35M+50.4%
$400K+14.3%$350K0.0%$350K0.0%$350K0.0%
$22.34M-1.1%$22.58M+6.9%$21.12M+0.4%$21.04M+4.3%$20.17M+6.2%
$3.78M+22.8%$3.08M-6.1%$3.28M-13.9%$3.81M-8.5%$4.16M+2.8%
$1.32M+2.1%$1.29M-8.9%$1.42M-15.5%$1.67M+0.3%$1.67M+24.7%
$2.6M+37.1%$1.9M-2.1%$1.94M-11.7%$2.19M-12.8%$2.52M-7.5%
$68.14M+111%$32.24M-3.3%$33.33M-12.5%$38.08M+51.8%$25.1M+21.4%
$1.94M+7.4%$1.81M-1.0%$1.83M+6.7%$1.71M-13.1%$1.97M+17.9%
$830K-3.6%$861K-3.3%$890K-19.3%$1.1M-3.0%$1.14M-6.0%
$69K-83.5%$418K-0.2%$419K0.0%$419K-1.2%$424K+0.2%
$70.98M+101%$35.33M-3.1%$36.46M-11.7%$41.32M+44.3%$28.63M+19.4%
$4.23M+41.0%$3M-20.7%$3.78M+98.9%$1.9M-32.2%$2.81M+23.4%
$269K+15.0%$234K+4.5%$224K+1.4%$221K-48.1%$426K+11.2%
$11.79M+2.5%$11.5M+5.4%$10.91M+17.0%$9.32M-20.7%$11.75M+14.9%
$33.08M+0.1%$33.05M+0.9%$32.76M+1.5%$32.27M+1.8%$31.7M
$58.17M-15.9%$69.19M+9.5%$63.19M+4.0%$60.74M-3.6%$63M+26.3%
$0$0$0$0$0
400M0.0%400M0.0%400M0.0%400M0.0%400M+13,333,233%
$341.85M+15.2%$296.72M+0.8%$294.24M+5.5%$278.79M+9.1%$255.55M+0.7%
-$329.04M+0.5%-$330.58M-3.0%-$320.97M-7.6%-$298.21M-2.9%-$289.92M-3.7%
$12.81M+138%-$33.86M-26.7%-$26.73M-37.6%-$19.42M+43.5%-$34.37M-32.7%
$70.98M+101%$35.33M-3.1%$36.46M-11.7%$41.32M+44.3%$28.63M+19.4%
$138K+26.6%$109K+43.4%$76K+24.6%$61K+165%$23K+130%
$69K-83.5%$418K-0.2%$419K0.0%$419K-1.2%$424K+0.2%
$830K-3.6%$861K-3.3%$890K-19.3%$1.1M-3.0%$1.14M-6.0%
$830K-3.6%$861K-3.3%$890K-19.3%$1.1M-3.0%$1.14M-6.0%
$69K-83.5%$418K-0.2%$419K0.0%$419K-1.2%$424K+0.2%
$1.94M+7.4%$1.81M-1.0%$1.83M
$830K-3.6%$861K-3.3%$890K-19.3%$1.1M-3.0%$1.14M-6.0%
$69K-83.5%$418K-0.2%$419K0.0%$419K-1.2%$424K+0.2%
$7.07M-12.7%$8.1M+19.5%$6.77M-4.3%$7.08M-15.8%$8.4M+14.2%
$7.07M-12.7%$8.1M+19.5%$6.77M-4.3%$7.08M-15.8%$8.4M+14.2%
$218K+30.5%$167K+29.5%$129K+4.9%$123K+4.2%$118K-45.4%
$269K+15.0%$234K+4.5%$224K+1.4%$221K-48.1%$426K+11.2%
$9.08M-29.6%$12.89M+0.8%$12.78M+27.9%$10M+5.7%$9.46M+13.7%
$2.74M-73.0%$10.14M+103%$5M-33.6%$7.52M-8.5%$8.22M+11.1%
$9.08M-29.6%$12.89M+0.8%$12.78M+27.9%$10M+5.7%$9.46M+13.7%
$1.19M-3.1%$1.23M-0.2%$1.23M-2.7%$1.27M-2.6%$1.3M-2.3%
$300K-21.7%$383K-23.7%$502K+40.2%$358K-36.5%$564K
$33.08M-4.0%$34.44M+5.1%$32.76M+1.5%$32.27M+1.8%$31.7M
$0.000.0%$0.000.0%$0.000.0%$0.000.0%$0.000.0%
61.4M+22.8%50M+0.2%49.9M+31.4%38M+17.7%32.3M+3.2%
10M0.0%10M0.0%10M0.0%10M0.0%10M0.0%
000-100%3.6M-0.7%3.6M-9.2%
000-100%3.6M-0.7%3.6M-9.2%
$5K+25.0%$4K0.0%$4K+33.3%$3K0.0%$3K0.0%
$0$0$0$0$0
$0.000.0%$0.000.0%$0.000.0%$0.000.0%$0.000.0%
7.4M0.0%7.4M0.0%7.4M0.0%7.4M0.0%7.4M+1.2%
$7.4M0.0%$7.4M0.0%$7.4M0.0%$7.4M0.0%$7.4M+1.2%
$00.0%$00.0%$00.0%$00.0%$00.0%
$400M0.0%$400M0.0%$400M0.0%$400M0.0%$400M0.0%
$61.41M+22.8%$50M+0.2%$49.89M+31.4%$37.98M+17.7%$32.27M+3.2%
$61.41M+22.8%$50M+0.2%$49.89M+31.4%$37.98M+17.7%$32.27M+3.2%
$9.08M-29.6%$12.89M+0.8%$12.78M+27.9%$10M+5.7%$9.46M+13.7%
$00.0%$00.0%$00.0%$00.0%$00.0%
$10M0.0%$10M0.0%$10M0.0%$10M0.0%$10M0.0%
$0$0$0-100%$3.59M-0.7%$3.62M-9.2%
$0$0$0-100%$3.59M-0.7%$3.62M-9.2%
$2.59M+19.4%$2.17M-8.2%$2.37M+6.7%$2.22M-10.7%$2.48M-17.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are TriSalus Life Sciences, Inc.'s total assets?
TriSalus Life Sciences, Inc. (TLSI) holds $71.0M in total assets, up 148.0% year over year.
How much debt does TriSalus Life Sciences, Inc. have?
TriSalus Life Sciences, Inc. carries $33.1M in total debt against $12.8M of shareholders' equity, a debt-to-equity ratio of 2.58.
How much cash does TriSalus Life Sciences, Inc. have?
TriSalus Life Sciences, Inc. holds $56.6M in cash and equivalents.
Can TriSalus Life Sciences, Inc. cover its short-term obligations?
Its current ratio is 5.78 — current assets exceed current liabilities.
Where does TriSalus Life Sciences, Inc.'s balance sheet data come from?
Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.